Skip to main content
. 2018 Sep 12;13:2859–2868. doi: 10.2147/COPD.S167379

Figure 1.

Figure 1

Identification of the study population.

Note: aParticipants with spirometry-defined COPD were identified using the 2016 GOLD COPD clinical diagnosis standards, requiring participants to have an FEV1/FVC ratio <0.70 after inhaling a β2-adrenergic bronchodilator medication.

Abbreviations: ACO, asthma–COPD overlap; FEV1/FVC, forced expiratory volume in 1 second/forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; NHANES, National Health and Nutrition Examination Survey.